Rmr Wealth Builders Seagen Inc. Transaction History

Rmr Wealth Builders

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$191.51 - $216.16 $27,194 - $30,694	-142 Reduced 8.56%	1,516 $321,000
Q2 2023 Jul 21, 2023	BUY	$187.64 - $206.25 $375 - $412	2 Added 0.12%	1,658 $319,000
Q1 2023 Apr 11, 2023	BUY	$127.59 - $203.08 $3,955 - $6,295	31 Added 1.91%	1,656 $335,000
Q4 2022 Feb 15, 2023	BUY	$117.37 - $139.17 $190,726 - $226,151	1,625 New	1,625 $208,000
Q3 2022 Nov 08, 2022	BUY	$135.27 - $180.11 $44,233 - $58,895	327 Added 25.83%	1,593 $218,000
Q2 2022 Aug 02, 2022	BUY	$108.81 - $179.33 $137,753 - $227,031	1,266 New	1,266 $224,000
Q4 2021 Feb 02, 2022	SELL	$142.57 - $190.86 $180,493 - $241,628	-1,266 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$142.45 - $169.82 $180,341 - $214,992	1,266 New	1,266 $215,000
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $171,011 - $203,952	-1,266 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $208,421 - $268,303	1,266 New	1,266 $222,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.